GeoVax Labs Inc.

GeoVax Labs Inc.
Stock Exchange Other OTC
EPS
$6.91
Market Cap
$384.3 K
Shares Outstanding
610 K
Public Float
251.91 M

Profile

Address
1900 Lake Park Drive
Smyrna Georgia 30080
United States
Employees -
Website http://www.geovax.com
Updated 07/08/2019
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines using its novel vaccine platform. It focuses on human immunodeficiency virus, zika virus, hemorrhagic fever viruses, and malaria. The company was founded by Harriet Latham Robinson and Donald G.

Financials

View All

Robert T. McNally
Director
Harriet Latham Robinson
Director